| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1039755175 |
| P356 | DOI | 10.1186/1756-9966-31-98 |
| P932 | PMC publication ID | 3533813 |
| P698 | PubMed publication ID | 23181722 |
| P5875 | ResearchGate publication ID | 233771644 |
| P2093 | author name string | Qiang Xiao | |
| Wen Luo | |||
| Wei-Yuan Wei | |||
| Yu-Bo Xie | |||
| Xiao-Tong Wang | |||
| Fan-Biao Kong | |||
| Chao Lian | |||
| P2860 | cites work | Quantifying heterogeneity in a meta-analysis | Q27860672 |
| Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasia | Q28204379 | ||
| CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer | Q28251382 | ||
| Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type | Q28268357 | ||
| Molecular classification of gastric cancer: a new paradigm | Q30500375 | ||
| Gastric cancer: the correlation between the clinicopathological factors and patients' survival (I). | Q33409856 | ||
| Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer | Q34613504 | ||
| CDX1 and CDX2 expression in intestinal metaplasia, dysplasia and gastric cancer | Q34853497 | ||
| Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis | Q35045566 | ||
| Gastric cancer epidemiology and risk factors | Q35067625 | ||
| Histotype-based prognostic classification of gastric cancer | Q35813471 | ||
| Expression and significance of homeodomain protein Cdx2 in gastric carcinoma and precancerous lesions | Q36082215 | ||
| P53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literature | Q36839254 | ||
| Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer | Q37328181 | ||
| Sublobectomy versus lobectomy for stage I non-small-cell lung cancer, a meta-analysis of published studies | Q37902547 | ||
| Meta-analysis for cyclin E in lung cancer survival | Q37975820 | ||
| siRNA targeting of Cdx2 inhibits growth of human gastric cancer MGC-803 cells | Q39352798 | ||
| Evidence for multiple micronutrient effects based on randomized controlled trials and meta-analyses in developing countries | Q39676970 | ||
| Overexpression of Cdx2 inhibits progression of gastric cancer in vitro. | Q39757057 | ||
| Statistical aspects of prognostic factor studies in oncology | Q42388377 | ||
| Expression levels of insulin-like growth factor-1 and multidrug resistance-associated protein-1 indicate poor prognosis in patients with gastric cancer | Q43284507 | ||
| Bias in meta-analytic research | Q43559593 | ||
| Transgenic Cdx2 induces endogenous Cdx1 in intestinal metaplasia of Cdx2-transgenic mouse stomach | Q44993621 | ||
| Technical note: The risk ratio, an alternative to the odds ratio for estimating the association between multiple risk factors and a dichotomous outcome | Q45686478 | ||
| Homeoprotein Cdx2 and nuclear PTEN expression profiles are related to gastric cancer prognosis | Q46816059 | ||
| Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa | Q47602801 | ||
| Expression of osteopontin and CDX2: indications of phenotypes and prognosis in advanced gastric cancer. | Q51825298 | ||
| Sensitivity analysis of intention-to-treat estimates when withdrawals are related to unobserved compliance status. | Q51900064 | ||
| CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions. | Q53259354 | ||
| The relationship among PDX1, CDX2, and mucin profiles in gastric carcinomas; correlations with clinicopathologic parameters. | Q53281894 | ||
| Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. | Q53384678 | ||
| Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach. | Q53393028 | ||
| CDX2 expression in the intestinal-type gastric epithelial neoplasia: frequency and significance. | Q53494631 | ||
| Genetic alterations of the Cdx2 gene in gastric cancer. | Q53550105 | ||
| CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer. | Q54723010 | ||
| CDX2 expression in the stomach with intestinal metaplasia and intestinal-type cancer: Prognostic implications | Q74806677 | ||
| Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis | Q79162539 | ||
| Expression of phosphorylated ERK1/2 and homeodomain protein CDX2 in cholangiocarcinoma | Q79776202 | ||
| CDX2 expression is increased in gastric cancers with less invasiveness and intestinal mucin phenotype | Q79800188 | ||
| Expression of CDX2 in benign tissue and adenocarcinoma of the prostate | Q80206159 | ||
| Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2 | Q80402277 | ||
| A clinicopathological study on the expression of cadherin-17 and caudal-related homeobox transcription factor (CDX2) in human gastric carcinoma | Q80916511 | ||
| Development of gastric carcinoma from intestinal metaplasia in Cdx2-transgenic mice | Q80945792 | ||
| Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis | Q81168618 | ||
| Effects of interferon therapy on development of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis: A meta-analysis of randomized controlled trials | Q83636312 | ||
| Detection and clinical significance of lymph node micrometastasis in gastric cardia adenocarcinoma | Q83690031 | ||
| Expression of CDX2 and villin in gastric cardiac intestinal metaplasia and the relation with gastric cardiac carcinogenesis | Q83886922 | ||
| P921 | main subject | meta-analysis | Q815382 |
| immunohistochemistry | Q899285 | ||
| P304 | page(s) | 98 | |
| P577 | publication date | 2012-11-26 | |
| P1433 | published in | Journal of Experimental & Clinical Cancer Research | Q13739415 |
| P1476 | title | Prognostic significance of Cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures | |
| P478 | volume | 31 |
| Q54542309 | Association between interleukin-4 -590C > T polymorphism and non-Hodgkin's lymphoma risk. |
| Q47117615 | CDX2 is involved in microRNA-associated inflammatory carcinogenesis in gastric cancer |
| Q50500966 | Curcuma wenyujin Y. H. Chen et C. Ling n-Butyl alcohol extract inhibits AGS cell Helicobacter pylori CagA+VacA+ promoted invasiveness by down-regulating caudal type homeobox transcription factor and claudin-2 expression. |
| Q92619889 | Fisher linear discriminant analysis for classification and prediction of genomic susceptibility to stomach and colorectal cancers based on six STR loci in a northern Chinese Han population |
| Q47097887 | Homeobox protein CDX2 as a prognostic biomarker in solid malignancies: a meta-analysis |
| Q47107972 | Metaplasia in the Stomach-Precursor of Gastric Cancer? |
| Q26830780 | New insights into the functions and localization of the homeotic gene CDX2 in gastric cancer |
| Q35628358 | Overexpression of caudal type homeobox transcription factor 2 inhibits the growth of the MGC-803 human gastric cancer cell line in vivo |
| Q92073923 | Prognostic Biomarkers for Gastric Cancer: An Umbrella Review of the Evidence |
| Q42034826 | Significance of glutathione peroxidase 1 and caudal-related homeodomain transcription factor in human gastric adenocarcinoma |
| Q54941919 | The impact of Mir-9 regulation in normal and malignant hematopoiesis. |
Search more.